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Cell shape changes associated with processes like cytokinesis and motility proceed on 
several second time-scales.  However, they are derived from much faster molecular 
events, including protein-protein interactions, filament assembly, and force generation.  
How these molecular dynamics define cellular outcomes remain unknown.  While 
accumulation of cytoskeletal elements during shape change is often driven by signaling 
pathways, mechanical stresses also direct proteins.  A myosin II-based mechanosensory 
system controls cellular contractility and shape during cytokinesis and under applied 
stress.  In Dictyostelium, this system tunes myosin II accumulation under mechanical 
stress by feedback through the actin network, particularly through the crosslinker 
cortexillin I.  Cortexillin-binding IQGAP proteins are major regulators of this system.  
We examined the dynamic interplay between these key cytoskeletal proteins using 
fluorescence recovery after photobleaching (FRAP) and fluorescence correlation 
spectroscopy (FCS), defining the short time-scale dynamics of these players during 
cytokinesis and under mechanical stress.  Actin and its polar cortex-enriched crosslinkers 
showed sub-second recovery, while equatorially enriched proteins including cortexillin I, 
IQGAP2, and myosin II recovered in 1-5 seconds.  Mobility of these equatorial proteins 
was greatly reduced at the furrow, compared to their interphase dynamics.  This mobility 
shift did not arise from a single biochemical event, but rather from global inhibition of 
protein dynamics by mechanical stress-associated changes in cytoskeletal structure.  
Thus, the equatorial proteins are stabilized under mechanical stress, which likely enables 
them to generate contractility at the furrow.  We further expanded our genetic and 
biochemical understanding of this mechanosensory system using a proteomics approach 
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to identify relevant protein-protein interactions.  We identified that, in addition to binding 
to each other, both cortexillin I and IQGAP2 also interact with myosin II under 
conditions that prevent myosin II-F-actin binding.  Thus, cooperativity between various 
mechanosensitive elements through macromolecular assemblies may provide a new 
mechanism for regulating cellular contractility.  Mechanical tuning of contractile protein 
dynamics provides robustness to the cytoskeletal framework responsible for regulating 
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Regulation of cell division is critical for normal development as well as disease.  An 
important step in such regulation is ensuring proper cytokinesis, which is the physical 
separation of a dividing cell into two daughter cells.  Cytokinesis proceeds through a 
series of stereotypical cell shape changes where the cell first rounds up, then elongates 
forming a cleavage furrow near the middle, whose constriction finally results in the 
separation of the daughter cells (Fig. 1.1).  Cytokinesis failure results in tetraploidy, 
which leads to anueploidy and can cause cancer.  In contrast, uncontrolled cell division 
will cause improper partitioning of genetic and cellular material, resulting in cell death.  
Thus, a detailed analysis of the molecular mechanisms of cytokinesis and their regulation 
is essential for understanding cellular outcomes and for development of new therapeutic 
strategies for diseases such as cancer. 
 
 
Figure 1.1: Stages of cytokinesis – A schematic diagram depicting the progression of cytokinesis in an 
amoeboid cell.  As the cell elongates during anaphase, a cleavage furrow forms where the contractile 
actomyosin network is recruited.  The furrow continues to ingress to form an intercellular bridge that 




The father of modern cytokinesis research, Ray Rappaport said “When I began working 
on cytokinesis, I thought I was tinkering with a beautifully made Swiss watch, but what I 
was really working on was an old Maine fishing boat engine: overbuilt, inefficient, never-
failed, and repaired by simple measures.” [1].  This statement highlights the complexity 
and built-in redundancy of cytokinesis, which involves crosstalk between several 
biochemical and mechanical pathways [2-4].  The interplay between these pathways 
confers the cell with the ability to robustly divide in diverse conditions.  The actin 
cytoskeleton and its associated proteins provide the framework for cytokinesis.  The 
mechanoenzyme myosin II generates contractile force, which causes the cell to constrict 
in the equatorial region.  Different actin crosslinkers and anchoring proteins play 
structural roles and help propagate forces within the actin network.  The spatiotemporal 
localization of these proteins at the cell cortex during cell division is critical to ensure 
successful cytokinesis. 
 
1.1. Important players in cytokinesis: A partial parts list 
In most eukaryotic cell types, actin and the motor protein myosin II are known to form a 
contractile structure in the equatorial region of a dividing cell, whose ingression drives 
cytokinesis.  Actin controls the cell mechanics by forming a highly dynamic network of 
semi-flexible filaments.  During the myosin II power stroke, myosin II pulls on the actin 
filaments as it releases the ATP hydrolysis products, thereby generating mechanical 
force.  Two myosin II heavy chains combine with two essential and two regulatory light 
chains (ELC and RLC respectively) to form a myosin II hexameric monomer.  Two 
monomers combine to form a parallel myosin II dimer, which then assembles into 
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functional bipolar thick filaments (BTFs) by dimer addition [5, 6].  Rho-kinase (ROCK) 
directs BTF assembly by activating myosin II through the phosphorylation of RLC.  
Additionally, heavy chain phosphorylation also controls BTF assembly and disassembly, 
both of which are required for normal cytokinesis [7].  Though myosin II is the major 
mechanoenzyme during cytokinesis, it is not necessary for cytokinesis.  Adherent 
Dictyostelium cells can divide fairly normally in the absence of myosin II using traction 
forces to help with the initial cell elongation followed by cortical tension-driven furrow 
thinning [8, 9].  The effects of cortical tension, which serves to minimize the surface 
area-to-volume ratio, are highly reminiscent of the surface tension of a liquid droplet, 
which also helps drive droplet breakup. 
 
In addition, several other actin-binding proteins, such as anillin and α-actinin in mammals 
and cortexillin I in Dictyostelium, help form a cross-linked actin network in the cell 
cortex and regulate the mechanical properties of the cortex during cytokinesis [10, 11].  
These proteins differ in their structure, actin-binding kinetics, force sensitivity and 
cellular localization.  The actin crosslinkers and myosin II collectively bear the force in 
the cortex.  Some crosslinkers also contain lipid-binding domains (such as the pleckstrin-
homology (PH) domain) that facilitate membrane attachment of the actin meshwork.  In 
animal cells, anillin is a potential scaffolding protein that may provide membrane 
anchoring and link Rho, actin and myosin II in the furrow [10].  Rho is a major regulator 
of animal cytokinesis, as it controls both actin polymerization through formins and 
myosin II activation through ROCK [12, 13].  The levels of GTP-bound active Rho in the 
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cleavage furrow are controlled by the guanidine-exchange factor (GEF) ECT2 and the 
GTPase-activating protein (GAP) MgcRacGAP [14].  
 
The microtubules and its associated proteins are also important for spatiotemporal 
regulation of cytokinesis.  In most cells, cytokinesis occurs in the plane perpendicular to 
the mitotic spindle near the center of the cell.  Thus, the spindle can deliver signals to the 
cell cortex that modulate cortical mechanics and direct cleavage-site selection and 
actomyosin contractile structure formation.  This signal can either be in the form of a 
biochemical factor or a purely mechanical cue like a change in cortical tension or 
membrane potential.  Many microtubule-based proteins such as the kinesin-6 family of 
proteins (mitotic kinesin-like protein-1, MKLP-1) are known to be important in 
cytokinesis and may localize asymmetrically in a dividing cell [14].  These proteins are 
believed to promote communication between the central spindle and the cell cortex. The 
astral microtubules, which point away from the spindle, are also important for regulating 
mechanics and inhibiting contractility in the polar cortex [15, 16]. 
 
Even though the plasma membrane is thought to have a relatively limited contribution to 
the cellular mechanical properties, proteins involved in membrane dynamics, membrane 
fission and fusion, and vesicle transport are important in cytokinesis.  The surface area of 
a dividing cell increases significantly as the furrow constricts [3, 17]. This requires the 
deposition of new membrane in the furrow region.  In addition, constant membrane 
remodeling is required to relieve mechanical stress.  Also, the plasma membrane is an 
important scaffold for many signaling proteins.  As the search for new genes that regulate 
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cytokinesis continues, many non-protein factors, including lipids and small metabolites, 
are also being examined as regulators of cytokinesis.  For example, the phosphoinositol-
4,5-bisphosphate (PIP2) is enriched in the cleavage furrow and can control the 
accumulation and retention of PIP2-binding proteins during cytokinesis  [18, 19].  In 
addition, many mechanical parameters, such as those described in the mechanics of 
cytokinesis section, can affect the kinetics of cell division.  To ensure robustness of 
cytokinesis, current models support the existence of multiple interacting, as well as 
parallel, mechanisms, thereby making the compilation of a comprehensive cytokinesis 
parts list challenging.   
 
1.2. Mechanics of cytokinesis 
Cytokinesis is fundamentally a mechanical process that requires major reorganization of 
the actin cytoskeleton and its associated proteins to promote cellular contractility at the 
cleavage site.  Hence, it is essential to supplement biochemical and genetic information 
with biophysical and mechanical studies to understand force generation, sensing, and 
transduction in a dividing cell.  A diverse tool set is available to study cell mechanics 
during cytokinesis, allowing characterization of various mechanical parameters [20]. 
While micropipette aspiration (MPA) studies are used to determine the elastic modulus 
and effective cortical tension, atomic force microscopy (AFM) measures the bending 
modulus. The elastic modulus determines the deformability of the cell surface, and the 
cortical tension is a complex parameter that measures the energy cost per unit increase in 
cell surface area [3]. The bending modulus reflects the stress required for bending a 
material. During cytokinesis, the initial deformation of a roughly spherical cell requires 
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deviation from its quasi-steady state. This is resisted by the cortical surface tension, 
which favors a spherical cell. However, as the furrow continues to ingress, the curvature 
in the cleavage furrow changes so that the cortical tension actually favors bridge thinning 
and abscission [3, 21]. Laser tracking microrheology (LTM) can be used to measure 
cortical viscoelasticity non-invasively. Viscoelasticity represents the time-dependent 
cellular response to stresses and affects the kinetics of furrow ingression by dampening 
the mechanical deformation, thereby allowing sufficient time for activation and 
stabilization of biochemical factors [3, 21]. 
 
Disruption of actin filaments by compounds such as latrunculin-A has established that the 
actin cytoskeleton is the main contributor of cell mechanics, though the cell membrane 
and microtubules also make some contribution [16, 22]. The actin cytoskeleton also 
undergoes remodeling with internally or externally generated mechanical stresses. The 
impact of these mechanical stresses has been uncovered using micropipette aspiration, 
which allows the application of a defined, localized stress on the cell, similar in 
magnitude to stresses experienced during cytokinesis [23]. Many proteins such as myosin 
II, which localize to the cleavage furrow cortex, also accumulate at sites where 
mechanical stress has been applied [6, 24, 25].  
 
In addition to the mechanical activation of biochemical reactions, the mechanical 
properties of the cell can be controlled biochemically. Knockdown or deletion of many 
actin crosslinkers and associated proteins softens the cell cortex significantly, leading to 
altered furrow ingression kinetics and a reduced ability to perform cytokinesis in 
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suspension culture (where cell-substrate adhesion is absent) [6, 25-27]. The biochemical 
constitution of the cell cortex governs its physical properties and determines how proteins 
respond to mechanical stresses.  For example, in the absence of myosin II, certain 
crosslinkers such as α-actinin show greater accumulation to sites of applied mechanical 
stress, while the myosin II mechanosensory response is amplified in mutants depleted of 
the small GTPase RacE which affects several polar crosslinkers [28]. Structurally, these 
crosslinkers can be divided based on their actin binding properties as those which form 
actin bundles and those which promote the formation of a crosslinked meshwork, which 
drives the sensitivity of their response to mechanical stress and accompanying network 
deformations [28].     
 
In Dictyostelium, the cortex becomes highly mechanoresponsive upon the onset of 
anaphase, where myosin II and cortexillin I show accumulation at lower pressures [24, 
28].  Interestingly, the overall deformability of the furrow is lower than the polar cortex, 
even though furrow undergoes major deformation during cytokinesis, which is attributed 
to an asymmetric cortical distribution of mechanosensitive proteins during cytokinesis 
[27]. This further illustrates the role of biochemical pathways in regulating cell 
mechanics. These findings demonstrate the intricate interplay between biochemical and 
mechanical pathways during cytokinesis.  
 
1.3. Feedback regulation of cytokinesis and mechanosensing 
As illustrated above, cytokinesis involves several proteins having multiple modes of 
regulation that controls when and where division occurs.  This multi-level regulation can 
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be emphasized using Dictyostelium cytokinesis as an example.  The amoeba 
Dictyostelium discoideum is a powerful model for cytokinesis studies due to its genetic 
homology and mechanical similarity to many mammalian cells, as well as its amenability 
for genetic, biochemical and mechanical perturbations. 
 
As the cell starts to divide, myosin II is enriched in the equatorial region where the 
cleavage furrow forms.  Cortexillin I, an actin crosslinker, also accumulates at the furrow 
where it regulates contractility along with myosin II [6].  The cooperative interactions 
between myosin II and cortexillin I are mechanosensitive and are mediated by actin 
filaments [5].  Both these proteins are also recruited to sites of applied stress during 
micropipette aspiration [5, 6].  Thus, these proteins form the core of a mechanoresponsive 
contractile unit, where myosin II is the force-generating element and cortexillin I anchors 
the actin network, and helps propagate forces through this network.  During cytokinesis, 
signals from the mitotic spindle direct the symmetry breaking and the initial recruitment 
of these proteins to the cell equator (Fig. 1.2).  Subsequently, the mechanical feedback 
between myosin II and cortexillin I controls the protein amount, and the contractility, at 
the furrow.  Further, two cortexillin I-binding proteins, IQGAP1 and IQGAP2, provide 
additional regulation of this mechanoresponsive system [25] (Fig. 1.2).  In the absence of 
IQGAP2, myosin II and cortexillin I fail to accumulate in response to applied stress due 
to inhibition by IQGAP1.  However, double mutant lacking both IQGAPs is highly 
mechanoresponsive indicating the IQGAPs are not required for mechanoresponsiveness, 
and only play regulatory roles.  Further, IQGAP2 also transduces the readout from the 
mechanosensor back to the spindle signaling proteins.  It is required for directing stress-
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dependent accumulation of the mitotic kinesin-like protein (MKLP) Kif12 and the 
chromosome passenger complex protein INCENP to the cell cortex upon aspiration [25] 
(Fig. 1.2).   
 
In addition to regulation at the cleavage furrow, the global cell mechanics are also highly 
controlled during cytokinesis.  Many actin crosslinkers such as dynacortin and fimbrin 
are enriched in polar cortex, and contribute to cortical dynamics [26, 27].  The small 
GTPase RacE is a global regulator of cortical mechanics and cytokinesis [29], and acts 
upstream of many actin crosslinkers including dynacortin and coronin [3, 21, 30] (Fig. 
1.2).  The overexpression of polar crosslinker inhibits myosin II mechanoresponsiveness, 
while the absence of RacE or dynacortin makes myosin II more responsive.  During 
cytokinesis, the equatorial mechanoresponsive unit (comprising of myosin II and 
cortexillin I) and the polar module (comprising RacE and other actin crosslinkers) exhibit 
inverse concentration gradient, promoting furrow ingression.  Though the equatorial and 
polar modules have complementary roles during cytokinesis, there is crosstalk between 
these modules.  RacE also acts upstream of 14-3-3, which is enriched in the polar cortex 
where it regulates cortical tension and steady state microtubule length [16] (Fig. 1.2).  14-
3-3 also binds to the myosin II heavy chain and promotes myosin II bipolar thick filament 
turnover at the furrow [16].  Thus, myosin II contractility at the furrow is regulated by the 





Figure 1.2: Pathways regulate cell mechanics and contractility during cytokinesis.  An equatorial 
module, comprising of myosin II, cortexillin I, IQGAPs and kif12/INCENP, tunes myosin II recruitment at 
the furrow.  The RacE-14-3-3-myosin II pathway and the polar crosslinkers control cortical tension at the 
poles. The signals from the mitotic spindle as well as the astral microtubules are central in directing the 
spatiotemporal function of these modules during cytokinesis [4]. 
  
Though the roles of myosin II and many actin crosslinkers in cytokinesis and contractility 
have been examined carefully, the molecular mechanisms for the recruitment and 
retention of these proteins remain unknown.  For example, a myosin II mutant lacking the 
motor domain can be enriched to the furrow region, though it is not tightly incorporated 
in the cortex suggesting that additional pathways may regulate myosin II furrow 
recruitment [31].  A genetic selection has identified novel roles for many proteins, 
including RMD1 (regulator of microtubule dynamics-1) and mmsdh (methylmalonate 
semialdehyde dehydrogenase), in rescuing defects in myosin II BTF assembly and furrow 
enrichment [32].  Thus, multiple parallel pathways regulate myosin II furrow localization 
and cellular contractility, thereby providing robustness to the cellular cytokinesis 
machinery.  Hence, Rappaport appropriately concluded that cytokinesis is indeed a 
complex shape change process, which is over-built and is hard to fail.  
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2. MATERIALS AND METHODS 
 
2.1. Cell strains and Culture 
A complete list of the strains used is provided in Table 1. Cells were grown in Hans’ 
enriched 1.5X HL-5 media (enriched with 8% FM medium) containing penicillin and 
streptomycin at 22
0
C on polystyrene petri dishes. Wild type strains used were KAx3 [33], 
Ax3:Rep orf+ (HS1000) [30] and rescued strains. Mutant cell lines used have been 
described previously – myoII [33], ctxA, ctxB, and ctxA/B [30, 34], iqg1, iqg2 and iqg1/2 
[34], and racE [30].  The plasmids for RFP-tubulin, GFP-cortexillin-I, GFP-IQGAP2, 
GFP-actin, mCherry-myosin-II and GFP have been described previously [24, 25, 28, 34].  
Cells were transformed with expression plasmids by electroporation using a Genepulser-
II electroporator (Bio-Rad, Hercules, CA).   
 
For the coimmunoprecipitation studies, FLAG-GFP-tagged constructs were made for 
cortexillin I, IQGAP2 and RacE by cloning into the pDM181vector.  The FLAG-GFP 
plasmid was used as a negative control.  A FLAG-GFP DNA fragment was amplified by 
polymerase chain reaction using the following primers: 
5’BglII-RBS-FLAG-SacI-GFP (Forward primer):  
5’ AAA AAA AGA TCT CTA TTA AAA TGG ATT ATA AAG ATG ATG ACG ATA 
AAG AGC TCA TGG ATC CAT CGA AAG GTG AAG 3’ 
 
3’SalI-Linker-SacI-GFP (Reverse primer):  
5’ AAA AAA GTC GAC GGA TCT TGA TAT CTT ACC TGA ACC TGA ACC GAG 




The amplified DNA was then cloned into pDM181 vector using BglII and SalI restriction 
enzymes.  Subsequently, cortexillin I, IQGAP2 or RacE were cloned into this plasmid 
using SalI and NotI sites in the vector.  The plasmid map for FLAG-GFP-pDM181 is 
given below. 
 
Figure 2.1: Plasmid map for FLAG-GFP-pDM181. 
 
Cells were then grown in selection medium containing 15 µg/mL G418 or 40 µg/mL 
hygromycin or both drugs when transforming two plasmids.  Expression levels were 
checked by fluorescence imaging or Western blotting.  Cells with comparable fluorescent 
protein expression were used for the experiments. 
 
2.2. Compression by Agarose Overlay 
Agarose overlay has been established as a method for applying uniform global 
mechanical stress, and has previously been shown to drive mechanosensitive 
accumulation of certain proteins at the cell cortex [25] (Fig. 2.2).  For compression, thin 


















0.2 mM CaCl2) were prepared according to the protocol described by Fukui et al. [35, 36] 
and modified by Kee et al. [25].  The cells were plated in imaging chambers for 1 hour.  
The culture medium was aspirated and cells were washed with MES starvation buffer 
twice to reduce the background fluorescence.  The buffer was removed completely and a 
sheet of agarose was carefully placed to cover the cells.  Imaging was started after the 
cells were completely flattened (about 2 minutes).  To ensure proper cell health, the 
flattened cells were not used beyond 10 minutes and were replaced during experiments.  
 
Figure 2.2: Myosin II accumulates along the lateral edges upon compression in regions of 
maximum stress. 3D-reconstruction of GFP-myosin II expressing Dictyostelium cells in absence 
or presence of compression.  
 
2.3. Latrunculin-A and Jasplakinolide Treatment 
Latrunculin-A and Jasplakinolide were obtained from Sigma-Aldrich.  All cells were pre-
treated with 0.1% DMSO for 4-6 hours.  For phalloidin and anti-actin staining, the cells 
were incubated with the drugs for 15 minutes.  For live cell imaging, drug stocks were 
freshly made in MES starvation buffer.  The cells plated in imaging chambers were 
washed with MES starvation buffer + 0.1% DMSO, followed by the addition of the drug-
containing buffer.  Imaging was performed after a 10 minute incubation, and each slide 




2.4. Fluorescence Recovery after Photobleaching (FRAP) 
FRAP experiments were performed using a Zeiss Axiovert 200 inverted microscope with 
LSM510-Meta confocal module, with a 63x (NA 1.4) objective. Cells expressing GFP-
tagged proteins were plated in glass-bottom imaging chambers for an hour.  The culture 
medium was replaced with MES starvation buffer immediately before imaging. A small 
region of the cell cortex was bleached using a 488 nm Argon laser, and the fluorescence 
recovery was recorded until recovery saturated (150 frames, 45-150 ms/frame depending 
on the protein).  The size and placement of the bleach region was kept relatively constant 
across measurements. 
 
For each frame, the average intensity of the bleached cortical region, reference 
(unbleached) region, and background was quantified using ImageJ (National Institutes of 
Health, Bethesda, MD) (Fig. 2.3A-B).  For photobleaching correction, the reference 
theoretical intensity (RTI) was calculated by fitting the background subtracted reference 
intensity to an exponential decay equation as follows: 
                      (1) 
Where, A, B and C are fitting parameters. 
 
The intensity of the bleached region was background subtracted and normalized to RTI 
(Fig. 2.3C). The normalized intensity (NI) was obtained by normalizing this to the pre-
bleach intensity (average of 4 pre-bleach images), and was fitted to a single exponential 
as follows: 
                 
        (2) 
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Where, m1, m2 are fitting parameters and k is the recovery rate. 
 
The recovery time, , and the immobile fraction, Fi were measured as: 
Recovery time,  =         (3) 
Immobile fraction, Fi = 
    
       
   (4)  
 
We also plotted the derivative of normalized intensity for each protein to confirm that our 
data fit a single-exponential, and did not require more complicated models.  The recovery 
times and immobile fractions calculated from FRAP are summarized in Tables 2-3. 
 
Figure 2.3: Calculation of immobile fraction and recovery time from FRAP. (A) An example 
confocal image of a GFP-cortexillin I-expressing cell illustrating the bleach, reference and 
background region used for FRAP measurements.  (B) Example fluorescence intensity curves 
showing changes in intensity of bleached and reference regions during a FRAP experiment.  (C) 
Example traces showing fluorescence recovery of GFP-cortexillin I in interphase and cleavage 
furrow cortex. 
 
2.5. Fluorescence Correlation Spectroscopy (FCS) 
FCS experiments were performed using a Zeiss AxioObserver with 780-Quasar confocal 
module & FCS, with a C-Apochromat 40x (NA 1.2) water objective. For purified 
proteins and dyes, the imaging plane was set 200 μm above the coverslip.  10 repetitions 
of 5 seconds each were collected and the average spectrum was used for measuring 
diffusion times.  For diffusion measurements in cells, the imaging plane was set through 
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the middle of the cell.  The acquisition time was reduced to 2 seconds to avoid 
complications from long range cellular and intracellular movement.  The average from 2-
7 repetitions was used to calculate diffusion times.  Any trace showing a persistent 
deviation from the mean or significant photobleaching was discarded.  The 
autocorrelation data was then fit to a single component, 3D-diffusion model with triplet 
state dynamics using the following equation: 
              
 
 
    
 
  
       
 
    
        (5) 
Where, 
  = correlation time 
   = diffusion time 
N = number of particles 
  = structural parameter 
         
         
     
  
 
(   = fraction of particles in triplet state and    = relaxation time for triplet state). 
 
100 nM Rhodamine 6G was used for pinhole alignment and structural parameter 
calculation (Fig. 2.4).  The measured value of the structural parameter was used for 
diffusion time calculation of other proteins.  All imaging was done in uncoated 35 mm-
glass bottom dishes (Coverslip No. 1.5) (MatTek Corp., Ashland, MA). 
 
In compressed cells, the cell height is comparable to the z-dimension of the FCS confocal 
volume.  Therefore, we also analyzed the FCS data using a 2D-diffusion model and 
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observed no significant differences in diffusion times as compared to those calculated 
using the 3D-diffusion model.   
 
Figure 2.4: Calibration of FCS experiments: (A) Example autocorrelation curves for rhodamine 6G 
diffusion as measured by FCS.  The autocorrelation data was fitted to a 1-component 3D diffusion model 
with triplet state dynamics.  The panel on right is the residual curve showing the goodness of fit.  (B) The 
distribution of diffusion times and structural parameter measured for rhodamine 6G by FCS.   
 
2.6. Calculation of Diffusion Coefficients 
Rhodamine 6G was used as a standard for calculating diffusion coefficients.  As the 
diffusion coefficient is inversely proportional to the diffusion time, we used the published 
value of the diffusion coefficient for rhodamine 6G and measured diffusion times for 
rhodamine 6G and the proteins of interest to calculate effective diffusion coefficients 
(    ). 
     
        
  
    (6) 
Where,   
    = diffusion coefficient for rhodamine 6G (= 426 μm
2
/s [37]) 
     = measured diffusion time for rhodamine 6G = 33 ± 2 μs 




We used purified mCherry to validate our diffusion coefficient calculation.  Our 
measured diffusion coefficient for mCherry (94 μm
2
/s) matched closely the published 
value for purified GFP (95 μm
2
/s [37]) under the same conditions (Table 4).  All 
diffusion time measurements and estimated diffusion coefficients are summarized in 
Table 4. 
 
2.7. F-actin Quantification by Phalloidin and Anti-actin Staining 
For quantifying the relative amount of F-actin, the cells were fixed and stained with 
TRITC-phalloidin (Sigma Aldrich) or anti-actin monoclonal antibody (Developmental 
Studies Hybridoma Bank, University of Iowa) as described in Luo et al. [5].  
Dictyostelium cells were plated on sterile 22x22 mm glass coverslips in 6-well 
polystyrene dishes at 70-80% confluency for 1 hour. The media was aspirated and 
replaced with 2 mL drug-containing media for 15 minutes.  The cells were washed with 
1X PBS, and immediately fixed on ice using acetone at -20
0
C for 3 minutes. The 
coverslips were transferred to a new 6-well dish and washed once with 1X PBS, followed 
by blocking in blocking buffer (1X PBS + 0.05% Triton X-100 + 0.5% BSA) for 30 min. 
The cells were stained with 0.16 µM TRITC-phalloidin for 1 hour or with anti-actin 
antibody overnight followed by 2 hour incubation with TRITC goat-anti-mouse 
secondary. All coverslips were washed 4 times with 1X PBT (1X PBS + 0.05% Triton X-
100) for 5 minutes each, and then once with 1X PBS. The coverslips were then mounted 




To quantify the relative amount of F-actin, all coverslips were imaged under identical 
conditions on a motorized Olympus IX71 microscope using a 40x (NA 1.3) objective 
with a 1.6x optovar (Olympus, Center Valley, PA). The integrated fluorescence intensity 
of the cells was quantified using ImageJ. At least 100 cells from more than 10 different 
fields were quantified. The intensity was normalized to the average fluorescence intensity 
of the untreated control for a given experiment.  The data shown represents three 
biological replicates. 
 
2.8. Cortical Tension Measurement Using Micropipette Aspiration 
The experimental set-up has been previously described in detail in Effler et al. (2006).  
0.01-0.6 nN/µm
2
 pressures were applied to a smooth region of the cell cortex through a 
~5 µm internal diameter glass micropipette (Rp = 2.3-3 μm).  A low pressure was first 
applied to form a pressure seal. The cell protrusion was allowed to stabilize for 30 
seconds before imaging. Subsequently, the pressure was gradually increased and imaging 
was resumed after the protrusion stabilized.  This was continued until the protrusion 
length became large (Lp > Rp) or the cell blebbed.  At each pressure, the protrusion length 
from five consecutive frames was averaged.  The critical pressure (ΔPcrit) was identified 
as the pressure where Lp = Rp, and the cortical tension (Teff) was calculated using the 
following equation: 











2.9. Anti-FLAG Coimmunoprecipitation 
The cytoskeletal fractionation protocol was modified from Reines and Clarke [38].  The 
cells were gently dislodged from the plate and centrifuged at 4000g for 5 minutes.  The 
cells were washed with 1X PBS and resuspended to a final concentration of 5x10
7
 
cells/mL for the ‘cytoskeletal’ sample (C) and 1x10
7
 cells/mL for the ‘soluble’ sample 
(S).  The cells were centrifuged at 5000g for 5 minutes, resuspended in 500 μL Lysis 
Buffer (100 mM PIPES pH 6.8, 2.5 mM EGTA, 1 mM MgCl2, 1 mM ATP, 0.5% Triton 
X-100 and protease inhibitor cocktail) and incubated on ice for 10 minutes with 
intermittent vortexing.  The samples were centrifuged at 15000g for 5 minutes at 4
0
C.  
The supernatant from ‘soluble’ sample was transferred to a fresh tube and kept on ice for 
coimmunoprecipitation.  The pellet from the ‘cytoskeletal’ sample was dissolved in 
Release Buffer (100 mM PIPES pH 6.8, 2.5 mM EGTA, 1 mM MgCl2, 1 mM ATP, 200 
mM NaCl and protease inhibitor cocktail), and incubated on a tube rotator for 15 minutes 
at 4
0
C.  The ‘cytoskeletal’ sample was then centrifuged at 15000g for 5 minutes at 4
0
C, 
and the supernatant was processed for coimmunoprecipitation.   
 
Forty-microliters IgG-Agarose beads and 40 μL anti-FLAG M2 Affinity Gel (Sigma 
Aldrich) per sample were aliquoted and washed three times with 1X TBS (50 mM Tris 
pH 7.4 and 150 mM NaCl). To reduce non-specific binding, the supernatants from 
cytoskeletal fractionation were incubated with 40 μL IgG-Agarose beads for 30 minutes 
at 4
0
C with continuous mixing.  The samples were centrifuged at 5000g for 1 minute, and 
the supernatants were transferred to tubes containing 40 μL pre-washed anti-FLAG resin, 
and incubated overnight at 4
0
C.  The resin was washed four times with 1X TBS, and 
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eluted with 0.1 M glycine, pH 3.5.  The eluted samples were then analyzed by mass 
spectrometry to identify potential binding partners.   
 
2.10. Mass Spectrometric Analysis 
Forty-microliters of eluted samples were incubated with 10 mM of tris-2 carboxyethyl 
phosphine (Sigma) for 20 min at RT with shaking, followed by alkylation with 10 mM of 
IAA (Sigma) for 20 min, at ambient RT, protected from light.  The reduced and alkylated 
proteins were acetone precipitated to remove solutes not compatible with downstream 
LC/MS/MS analysis.  Final pellet was air-dried.  5 μg of endoproteinase Lys-C 
(Promega, Madison, WI)) was reconstituted in 650 μL of digestion solution (0.1% 
RapiGest (Waters, Milford, MA), 20% ACN, 50 mM Ammonium Bicarbonate).  20 μL 
of that solution was added to each acetone precipitated sample.  Protein pellet was 
allowed to digest for 2 hours at 37
0
C with constant shaking.  Following addition of 1 μg 
of trypsin (Promega, Madison, WI) in 20 μL of digestion solution, enzymatic proteolysis 
continued overnight under the same conditions.  TFA was added to deactivate enzymes.  
Samples were desalted using UltraMicro Spin C18 columns (NestGroup, Southborogh, 
MA) according to the manufacturers instructions.  Collected peptides were lyophilized 
and reconstituted in 10 μL of water with 0.1% fluoroacetic acid (FA) Optima (Thermo 
Fisher Scientific).   
 
Four-microliter aliquots of each tryptic protein digest solution were analyzed on EASY n-
LC 1000 (Thermo Scientific) coupled to Orbitrap-Elite (Thermo Fisher) mass 
spectrometer.  Peptides were separated on Acclaim PepMap RSLC column (Thermo 
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Scientific), with 50 μm inner diameter, 15 cm length, packed with C18 reversed phase 2 
μm particles, 100 A pore size), using mobile phase linear gradient from 5% B to 20% B 
in 40 min continued to 35% B in 10 min at 300 μL/min flow rate, where mobile phase A 
was composed of 0.1% (v/v) Formic acid in water and mobile phase B 0.1% (v/v) Formic 
acid in acetonitrile. 
 
2.11. Tandem Mass Spectrometric Analysis (LTQ-Orbitrap XL) 
Eluting peptides were ionized via Nanospray Flex ion source (Thermo Scientific) 
operated at following settings: source voltage 2.00V, capillary temperature 275.00 C and 
S-lens RF level 60.  
 
The Orbitrap –Elite mass spectrometer was operated in data dependent mode. MS 
precursor scan spectra (m/z 350-1800) were acquired in the Orbitrap with mass resolution 
of 60,000 full-width half-maximum (at m/z 400).  The fifteen most intense ions from 
each MS scan were automatically targeted for CID (collision induced dissociation) 
fragmentation (MS/MS) in the LTQ (linear ion trap) with dynamic exclusion 90 sec.  For 
MS1, AGC (automatic gain control) target was set to 1x10
6
 with maximum accumulation 
time 250 ms.  Only ions of 1000 minimum signal intensity were selected for MS2 
fragmentation.  MS2 spectra were acquired in a rapid scan mode in the LTQ (linear ion 
trap) using targeted setting of 10x10
4
 ions and accumulation time of 150 ms.  Normalized 
collision energy was set at 35%.  The default charge state was set at two.  The isolation 




2.12. Peptide Identification via MASCOT Database Search  
Raw MS data were searched against the UniProt Dictyostelium discoideum database. 
(37,261 entries; October, 2013 version) using Sorcerer 2™-SEQUEST® (Sage-N 
Research, Milpitas, CA) with postsearch analysis performed using the Trans-Proteome 
Pipeline, implementing PeptideProphet and ProteinProphet  algorithms.  Sequest 
(Thermo Fisher Scientific, San Jose, CA: version 1.0) was set up with following search 
parameters: semienzyme digest using trypsin (after Lys or Arg) with up to two missed 
cleavages; monoisotopic precursor mass range of 400–4500 amu; and oxidation (Met), 
carbamidomethylation (Cys), and acetylation(Lys) were specified as variable 
modifications. Peptide mass tolerance was set to 50 ppm, fragment mass tolerance was 
set to 1 amu, fragment mass type was set to monoisotopic, and the maximum number of 
modifications was set to four per peptide.  
 
Scaffold (version Scaffold_4.4.1.1, Proteome Software Inc., Portland, Or) was used to 
validate peptide and protein identifications.  Error rates (false discovery rates) and 
peptide probabilities (p) were calculated by Peptide Prophet, accepted peptide 
identifications had greater than 95% probability with Scaffold delta-mass correction. 
Protein Probabilities were assigned by Protein Prophet algorithm, only proteins 
identification at greater than 95% probability, which contained at least two identified 





2.13. Comparative analysis of binding partners 
The normalized spectral counts were used for identifying proteins that were up- or down-
regulated in the experimental samples as compared to the control group based on 
quantifying the protein total spectral count.  We applied the G-test of independence to 
determine the significance of difference in the normalized spectral count (average of 3 
replicates) for the experimental and control group.  We defined f1 = normalized spectral 
counts/protein in the control sample (FLAG-GFP), f2 = normalized spectral 
counts/protein in the experimental sample (FLAG-GFP-cortexillin I, for example).  When 
a protein was absent from one of the samples, it was assigned the normalized spectral 
count of 0.0001.  The G value was calculated as  
        
  
     
        
  
     
  
Where avgf1 = avgf2 = (f1 + f2)/2 
 
A Chi-squared distribution with one degree of freedom was assumed, with a p value less 
than 0.05 considered significant.  Thus, a protein was considered differentially expressed 
if the calculated G value was greater than 3.841. 
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3. RESULTS AND DISCUSSION 
Cytokinesis is a complex shape change process involving a large number of proteins 
which work together in a highly coordinated manner.  The crosstalk between various 
cytoskeletal modules ensures high fidelity of cytokinesis. Previous genetic and 
mechanical studies in Dictyostelium have identified a mechanoresponsive control system 
that regulates contractility at the cleavage furrow of a dividing cell.  The mitotic spindle 
and mechanical stress direct recruitment of contractile proteins – myosin II and 
cortexillin I – at the furrow, driving furrow ingression.  Cellular contractility is further 
regulated by the cortexillin-binding IQGAP proteins, providing tunability to the 
mechanosensory system.  However, how these proteins interact at a molecular level to 
affect mechanosensory responses remains unknown.   
 
In this study, we examined the dynamics and mobility of key mechanoresponsive 
proteins using fluorescence recovery after photobleaching (FRAP) and fluorescence 
correlation spectroscopy (FCS) to understand how they are recruited to and retained at 
the cleavage furrow.  We observed that the mechanoresponsive proteins, including 
myosin II, cortexillin I and IQGAP2, show marked reduction in mobility at the cleavage 
furrow compared to the interphase cortex. This indicates that these proteins are forming 
stable complexes at the furrow.  Further, the shift in protein mobility at the furrow is 
driven by mechanical stress, and is robust to many genetic perturbations.  In addition, we 
used proteomics to identify protein-protein interactions important for 
mechanoresponsiveness. We found that myosin II can associate with both cortexillin I 
and IQGAP2, further suggesting the existence of large scale assemblies of 
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mechanoresponsive complexes.  Thus, this study gives new insight into how different 
cytoskeletal elements can work together to respond to mechanical stress, and regulate 
contractility during cytokinesis. 
 
3.1. Equatorial proteins have slower recovery times than polar 
crosslinkers, and exhibit reduced mobility at the cleavage furrow 
The short time-scale dynamics of proteins regulate their recruitment and localization.  
Actin-associated proteins may be classified into two groups – the equatorially enriched 
cleavage furrow proteins and the polar or globally distributed proteins ([27], Fig. 3.1A).  
We used fluorescence recovery after photobleaching (FRAP) to examine the dynamics of 
these groups in interphase and dividing Dictyostelium cells, and to explain differences in 
their spatiotemporal localization.  We measured the fluorescence intensity in the bleached 
region until the recovery curve saturated (10-25 s), allowing accurate calculation of 
recovery times and immobile fractions for key cytoskeletal proteins (Fig. 2.3).  The 
characteristic recovery time is dominated by binding-unbinding rates, while the immobile 
fraction represents the population that does not turn over during the experiment (Fig. 
3.1B).  As Dictyostelium cells are highly motile, longer acquisitions can show additional 
long-scale recovery due to cellular motility instead of protein dynamics.  Thus, for this 
study we only measure the fast dynamic recovery and mobility.  In interphase cells, GFP-
actin recovers within a second, establishing the dynamicity of the actin network (Fig. 
3.1C, D, Table 2).  The cortical actin recovery times and immobile fractions were 
significantly higher than for GFP or cytoplasmic GFP-actin (Fig. 3.1C, 1D).  Thus, the 
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cortical FRAP measurements report on the dynamics of the cortical cytoskeletal network, 




Figure 3.1: Cytoskeletal protein dynamics measured by FRAP. (A) Cytoskeletal proteins are 
asymmetrically localized during cytokinesis.  (B) From FRAP analysis, the network release rate is 
inversely proportional to the recovery time (), while the immobile fraction (dark red circles) represents the 
protein population that does not turnover during the experiment.  The protein mobile fraction is represented 
by light orange circles.  The thick and thin lines represent the immobile and mobile populations of actin, 
respectively.  (C) Recovery times and immobile fractions for soluble GFP and cytoskeletal proteins at the 
cell cortex and in the cytoplasm in interphase cells as measured by FRAP.  Cytoskeletal proteins show 
slower recovery in the cortex than in the cytoplasm.  (D) Distribution of recovery times and immobile 
fractions for soluble GFP and cytoskeletal proteins at the cell cortex and in the cytoplasm. Asterisks 
represent the significance of difference between interphase and furrow measurements where ns: p >0.05, *: 




Genetic, biochemical and mechanical studies have demonstrated cross-talk between the 
polar and equatorial modules [3, 16].  However, how these proteins interact dynamically 
to control these processes is unknown.  Here, we study the dynamics of proteins 
important for cytokinesis to develop a mechanistic understanding of how cells divide and 
regulate their shape.  This would provide insight into how the fast molecular events 
governing cytokinesis, including motor activity, actin filament turnover and 
rearrangement, and crosslinker interactions, regulate much slower cell shape changes.   
 
Interestingly, we observed that actin dynamics changed during cytokinesis as the 
recovery time increased and the immobile fraction decreased in the furrow (Fig. 3.2, 
Table 2).  In comparison, the dynacortin and fimbrin recovery times at the furrow 
increased significantly, while their mobility was unaffected (Fig. 3.2, [27]).  The polar 
cortex dynamics of dynacortin and fimbrin were similar to interphase values, while actin 
showed increased mobility at the poles (data not shown).  Myosin II, cortexillin I and 
IQGAP2, which localize to the cleavage furrow, recovered more slowly (1.5-5 s) than 
actin or polar crosslinkers in the interphase cortex (Fig. 3.2, Table 2).  Their much 
slower recovery than that of soluble GFP demonstrates that the fluorescence recovery is 
dominated by unbinding events at the cortex instead of diffusion.  Further, their 
cytoplasmic recovery times are significantly faster than those in the cortex (Fig. 3.1C, 
D), indicating that the equatorial proteins form stable complexes at the cortex with slower 
unbinding.  Cortexillin I recovery was slower at the furrow than in interphase, while 
myosin II and IQGAP2 showed no change.  In contrast, myosin II recovery slows in 




The equatorial proteins had high mobility during interphase compared to other proteins 
(Fig. 3.2).  The mobility of cortexillin I and IQGAP2 in the interphase cortex were 
comparable to those in the cytoplasm (Fig. 3.1C, D).  However, the immobile fractions 
for these proteins increased significantly at the cleavage furrow (Fig. 3.2, Table 2).  The 
magnitude of mobility shift for cortexillin I and IQGAP2 was higher than for myosin II 
[16, 27, 41].  Thus, we focused on cortexillin I and IQGAP2 dynamics for the remainder 
of this study.  The reduction in protein mobility at the furrow suggests that these proteins 
are stabilized at the cortex during furrow ingression, consistent with their slower recovery 
times.  The high immobile fractions also likely promote their furrow enrichment. 
Therefore, determining the factors that cause this mobility shift is essential to explaining 
how the contractile proteins accumulate and remodel during furrow ingression.    
 
Figure 3.2: Changes in cytoskeletal protein dynamics during cytokinesis. Recovery times and immobile 
fractions of different cytoskeletal proteins in the interphase cortex and at the cleavage furrow.  Equatorially 
enriched proteins – myosin II, cortexillin I and IQGAP2 – have markedly reduced mobility at the cleavage 
furrow.  Values plotted are mean ± SEM; sample sizes are listed on the bars (see Table 3.1).  Asterisks 
represent the significance of difference between interphase and furrow measurements where ns: p >0.05, *: 
p <0.05, **: p <0.005, ***: p <0.0005 based on ANOVA with Fischer’s LSD post-test.  #: FRAP data for 




3.2. Genetic control of protein dynamics is suppressed at the furrow 
Previous genetic studies established the functional interplay between myosin II, 
cortexillin I, and the IQGAPs in governing protein accumulation and contractility at the 
cleavage furrow and in responding to mechanical stress [25] (Fig. 3.3A). Thus, we tested 
whether the same genetic relationships also dictate protein dynamics, regulating their 
furrow accumulation.  We conducted FRAP on cortexillin I and IQGAP2 at the 
interphase cortex and the furrow in cell lines lacking key components of this 
mechanoresponsive system (Fig. 3.3B).   
 
 
Figure 3.3: Cortexillin I and IQGAP2 dynamics at the cleavage furrow.  (A) A myosin II-cortexillin I-
actin-based mechanosensory system regulates contractility at the furrow, and IQGAP proteins regulate 
accumulation of the contractile proteins.  (B) Confocal images showing photobleaching and fluorescence 
recovery of GFP-cortexillin I and GFP-IQGAP2 in the cortex of interphase cells and at the cleavage 
furrow.  Scale bar is 5 μm. 
 
Cortexillin I recovery time increased at the furrow compared to the interphase cortex in 
wild type (WT) cells (Fig. 3.4A, C, Table 2).  However, this slower recovery was not 
observed in myosin II (myoII) and iqgap2 (iqg2) null cells (Fig. 3.4A, C, Table 2).  In 
contrast, while IQGAP2’s recovery time was unaltered at the furrow in WT cells, 
IQGAP2 had significantly higher recovery time at the furrow in myoII cells (Fig. 3.4B, 
D, Table 2).  Both cortexillin I and IQGAP2 had >2-fold higher immobile fractions at the 
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cleavage furrow (Fig. 3.4A-D, Table 2).  Cortexillin I immobile fractions were higher in 
interphase myoII and iqg2 compared to WT, but were unchanged at the furrow in these 
mutants (Fig. 3.4A, C, Table 2).  This demonstrates that while myosin II and IQGAP2 
are important for maintaining a mobile pool of cortexillin I, additional factors such as 
mechanical stress could dominate cortexillin I mobility at the furrow, ensuring its 
recruitment during cytokinesis, as cortexillin I also shows mechanical stress-dependent 
accumulation [6, 25].  Consistently, the cleavage furrow localization of cortexillin I was 
not affected in any of the mutants tested.  IQGAP2 immobile fraction was also higher in 
interphase myoII as compared to WT (Fig. 3.4B, D, Table 2), suggesting that myosin II 
drives the dynamic remodeling of the cytoskeletal network.  Myosin II’s full power 
stroke is required for this mobility regulation, as the 10-fold slower S456L mutant 
myosin II, which only takes a 2-nm step (1/4 of WT) [6, 27, 42], fails to rescue the 
IQGAP2 and cortexillin I mobility defects seen in myoII cells (Fig. 3.5).  Although 
myosin II regulates the actin cortex dynamics in epithelial cells [43, 44], deletion of 






Figure 3.4: Changes in cortexillin I and IQGAP2 dynamics at the cleavage furrow in genetic mutants. 
(A, B) Recovery times and immobile fractions for GFP-cortexillin I (A) and GFP-IQGAP2 (B) in different 
genetic mutants in the cortex of interphase and dividing cells.  (C, D) Distribution of recovery times and 
immobile fractions for GFP-cortexillin I (C) and GFP-IQGAP2 (D) in different genetic mutants in 
interphase and dividing cells.  Values plotted are mean ± SEM; sample sizes are listed on the bars (see 
Table 2).  p values represented as ns: p >0.05, *: p <0.05, **: p <0.005, ***: p <0.0005 based on ANOVA 
with Fischer’s LSD post-test.  Asterisks above the furrow measurement represent significance of difference 






Figure 3.5: Effect of myosin II motor activity on cortexillin I and IQGAP2 dynamics.  Distribution of 
recovery times and immobile fractions for GFP-cortexillin I (A) and GFP-IQGAP2 (B) in WT, myoII and 
S456L myoII cells.  p values are represented as ns: p >0.05, *: p <0.05, **: p <0.005, ***: p <0.0005 based 
on ANOVA with Fischer’s LSD post-test. 
 
 
Figure 3.6: Actin dynamics are unchanged in different genetic mutants (A) Recovery times and 
immobile fractions for GFP-actin in different genetic mutants in the interphase cortex.  (B) Distribution of 
recovery times and immobile fractions of GFP-actin in the interphase cortex of different mutants.  Values 
plotted are mean ± SEM; sample sizes are listed on the bars (See Table 2).  
 
The deletion of IQGAP1 (iqg1) did not affect the interphase or furrow dynamics of either 
cortexillin I or IQGAP2 (Fig 3.4, Table 2), in agreement with its role as a damper of 
stress-dependent protein accumulation [25].  Because IQGAP1 and IQGAP2 interact with 
distinct domains of cortexillin I [34, 45, 46], we also studied cortexillin I dynamics in the 
iqg1/2 double mutant.  Here, cortexillin I still showed faster recovery at the furrow as 
compared to WT, similar to iqg2 (Fig. 3.7, Table 2).  However, the immobile fraction at 
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the furrow was higher in the double mutant compared to the WT or iqg2 mutant (Fig. 3.7, 
Table 2).  The iqg1/2 cells show enhanced stress-dependent protein accumulation, while 
iqg2 cells are unresponsive due to IQGAP1 inhibition [25]. Thus, the reduced mobility of 
cortexillin I at the furrow is likely due to mechanical stresses locking in the cytoskeletal 
network of these highly mechanoresponsive cells. 
 
Figure 3.7:  IQGAP2 affects cortexillin I dynamics (A) Mean recovery times and immobile fractions for 
GFP-cortexillin I in WT, iqg2 single, and iqg1/2 double mutants.  (B) Distribution of recovery times and 
immobile fractions for GFP-cortexillin I in WT, iqg2 single, and iqg1/2 double mutants.  Values plotted are 
mean ± SEM; sample sizes are listed on the bars (See Table 2).  p values are represented as ns: p >0.05, *: 
p <0.05, **: p <0.005, ***: p <0.0005 based on ANOVA with Fischer’s LSD post-test. 
  
To examine molecular scale events driving the protein dynamics changes, we used 
fluorescence correlation spectroscopy (FCS) to measure the in vivo diffusion of 
cortexillin I and IQGAP2 across various mutant backgrounds.  FCS experiments were 
performed in the cytoplasm as cell movement precluded positioning the confocal volume 
at the cortex.  We compared the diffusion time for cortexillin I and GFP in the cytoplasm 
to that of purified proteins in vitro. GFP had 5-fold reduction in diffusion time in cells 
while cortexillin I showed >8-fold slower diffusion (Fig. 3.8A, Table 4), confirming that 
cortexillin I is a part of large molecular assemblies.  The deletion of myosin II did not 
impact the cytoplasmic diffusion of either cortexillin I or IQGAP2 though it increased the 
immobile fraction of both proteins at the cortex (Fig. 3.8B, C), implying that myosin II 
affects protein dynamics by regulating contractility and cytoskeletal structure.  The 
diffusion time for cortexillin I was increased by ~30% in iqg2 cells (Fig. 3.8B, Table 4).  
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This suggests that without IQGAP2, the effective mass of the cortexillin I complex 
roughly doubles as diffusion time is approximately proportional to the cube root of the 
effective molecular weight of the diffusing species.  As expected, cortexillin I diffusion 
also showed a similar trend in the iqg1/2 double mutant (Fig. 3.8B, Table 4).  Thus, the 
changes in cortexillin I mobility could arise from changes in biochemical interactions in 
the absence of IQGAP2.  
 
 
Figure 3.8: Diffusion times for cortexillin I and IQGAP2 measured by FCS (A) Diffusion times for 
purified mCherry and GFP-cortexillin I in vitro, and GFP and GFP-cortexillin I in cellular cytoplasm as 
measured by FCS. (B, C) Cytoplasmic diffusion times measured by FCS for GFP-cortexillin I (B) and 
GFP-IQGAP2 (C) in different mutants.  Calculated diffusion coefficients are provided in Table 4.  p values 
are represented as ns: p >0.05, *: p <0.05, **: p <0.005, ***: p <0.0005 based on ANOVA with Fischer’s 
LSD post-test. 
 
Collectively, the FRAP and FCS experiments enabled us to attribute changes in 
cortexillin I mobility to either protein-protein interactions (in iqg2 and iqg1/2) or to 
cortex re-structuring (in myoII).  We demonstrated that the dynamics of cortexillin I and 
IQGAP2 at the cleavage furrow are well conserved across mutants, though differences 
emerge during interphase (Fig. 3.9).  As cleavage furrow contractility is common to all 
cells, we hypothesized that mechanical stresses acting at the furrow could override the 
biochemical signals to define cleavage furrow protein dynamics.  Physical mechanisms 
such as myosin II-mediated force generation, Laplace pressure-mediated furrow thinning, 
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and protrusive forces from the polar cortex drive furrow ingression [9].  Thus, we next 
examined whether mechanical stresses at the cleavage furrow were sufficient to shift the 
dynamics of these mechanoresponsive proteins. 
    
 
Figure 3.9: Schematic showing the effect of key cytoskeletal proteins on the dynamics of cortexillin I 
and IQGAP2, based on FRAP measurements. 
 
3.3. Mechanical stress drives the reduction in cleavage furrow 
mobility of cortexillin I and IQGAP2 
In addition to enrichment at the cleavage furrow, myosin II, cortexillin I and IQGAP2 
accumulate to sites of externally applied mechanical stress, thereby allowing the cell to 
retract against this stress [6, 24, 25].  Hence, we applied compression using agarose 
overlay to test if mechanical stress, as compared to biochemical signaling, affects protein 
dynamics changes at the cleavage furrow.  Flattening of the cells drives the accumulation 
of the mechanoresponsive proteins studied here to the cell cortex to counter the 
compressive stress [25, 28].  The ratio of fluorescence intensity in the cortex to that in the 
cytoplasm is dependent on the thickness of agarose and plating density (T. Luo and 
Robinson, unpublished data), confirming that the increase in cortical intensity is driven 
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by mechanical stress and is not simply due to volume effects.  Further, soluble GFP does 
not change in cortical intensity upon compression [25].  
 
We examined cortexillin I and IQGAP2 interphase dynamics in presence or absence of 
compression across mutants studied above (Fig. 3.10, Table 2).  Cortexillin I exhibited a 
slower recovery time under compression, but IQGAP2’s recovery time was unaffected 
(Fig. 3.11A-D).  Both cortexillin I and IQGAP2 showed a >2-fold increase in the 
immobile fraction under compression (Fig. 3.11), similar to the observation at the furrow 
(Fig. 3.4).  By FCS, the cortexillin I diffusion time also doubled under compression, 
while IQGAP2 diffusion was unaffected (Fig. 3.13, Table 4).  Both the recovery time 
and immobile fraction for IQGAP2 increased in compressed myoII compared to WT (Fig. 
3.11B, D, 3.12, Table 2).  Cortexillin I and IQGAP2 dynamics under compression did 
not change in other mutants as compared to WT (Fig. 3.11, 3.12, Table 2).  The 
cortexillin I mobility shift in iqg2 cells under compression was higher than that observed 
at the furrow (Fig. 3.11A, 3.4A), suggesting that under compression cortexillin I directly 
responds to mechanical stress, compared to the cleavage furrow where biochemical 
signals through IQGAP2 also contribute to cortexillin I mobility.  Importantly, both 
compression and cleavage furrow showed a consistent, >2-fold increase in immobile 
fractions of both cortexillin I and IQGAP2 compared to the unstressed, interphase cortex 
across various mutants (Fig. 3.4, 3.11).  This validates the importance of mechanical 
stress in driving the dynamics of equatorially enriched proteins at the cleavage furrow, 





Figure 3.10: Changes in cortexillin I and IQGAP2 dynamics upon compression. Confocal images 
showing photobleaching and fluorescence recovery of GFP-cortexillin I and GFP-IQGAP2 in the cortex of 
interphase uncompressed and compressed cells.  Scale bar is 5 μm. 
 
 
Figure 3.11: Changes in cortexillin I and IQGAP2 dynamics upon compression in genetic mutants.  
(A, B) Recovery times and immobile fractions for GFP-cortexillin I (A) and IQGAP2 (B) in different 
genetic mutants in absence or presence of compressive stress.  (C, D) Distribution of recovery times and 
immobile fractions for GFP-cortexillin I (C) and IQGAP2 (D) in different genetic mutants in absence or 
presence of compressive stress.  Values plotted are mean ± SEM; sample sizes are listed on the bars (See 
Table 2). p values are represented as ns: p >0.05, *: p <0.05, **: p <0.005, ***: p <0.0005 based on 




Figure 3.12: Schematic showing the effect of key cytoskeletal proteins on the dynamics of cortexillin I 
and IQGAP2 under compression, based on FRAP measurements. 
 
 
Figure 3.13: Protein diffusion under compression. Diffusion times for GFP, cortexillin I and IQGAP2 
measured by FCS in WT and myoII cells.  Calculated diffusion coefficients are provided in Table 4.  p 
values are represented as ns: p >0.05, *: p <0.05, **: p <0.005, ***: p <0.0005 based on ANOVA with 
Fischer’s LSD post-test. 
 
In addition, by measuring dynamics of cortexillin I and IQGAP2 in cells lacking the 
small GTPase racE (racE), we assessed the contribution of cortical tension on protein 
dynamics, as racE is a major regulator of cortical mechanics [21, 27, 30].  For cortexillin 
I, the immobile fraction was higher and the recovery time was shorter in racE cells, while 
IQGAP2 dynamics were unchanged (Fig. 3.14).  Thus, cortexillin dynamics are not only 
affected by mechanical stress but also by general cortical mechanics.  Furthermore, the 
mobility and recovery times of GFP-actin were not affected by compression.  Overall, 
cortexillin I dynamics are more sensitive to compressive stresses than the dynamics of 





Figure 3.14: The effect of RacE on cortexillin I and IQGAP2 dynamics. (A) Average recovery times 
and immobile fractions of GFP-cortexillin I and GFP-IQGAP2 in WT and racE null cells.  (B) Distribution 
of recovery times and immobile fractions of GFP-cortexillin I and GFP-IQGAP2 in WT and racE null 
cells. Values plotted are mean ± SEM; sample sizes are listed on the bars. p values are represented as ns: p 
>0.05, *: p <0.05, **: p <0.005, ***: p <0.0005 based on ANOVA with Fischer’s LSD post-test. #: The 
immobile fraction for cortexillin I in racE null cells is bimodal (see panel B); hence SEM is not shown. 
 
As compression reduced cell height by up to 4-fold, we measured GFP dynamics to 
examine the impact of altered protein transport and cellular structure upon compression. 
The immobile fraction and diffusion time for GFP nearly doubled (Fig. 3.15, 3.13), 
suggesting sieving effects may become significant under compression.  The altered GFP 
dynamics under compression confirm that network structure and intracellular 
environment are important contributors to mechanical stress-dependent protein dynamics.  
However, in myoII cells, GFP FRAP dynamics did not change upon compression, rather 
GFP diffusion was faster in compressed myoII cells (Fig. 3.15, 3.13),  suggesting that 
myosin II is important for stabilizing the cortex under mechanical stress, and in its 
absence the cortical dynamics are dominated by passive diffusive behaviors [47].  As the 
actin cytoskeleton forms a highly dense meshwork in Dictyostelium, structural changes 
between interphase and furrow cortex cannot be resolved by confocal and electron 
microscopy [27].  Thus, we next chemically perturbed the cytoskeleton to determine how 





Figure 3.15: GFP dynamics under compression. (A) Average recovery time and immobile fraction for 
GFP in WT and myoII cells.  (B) Distribution of recovery time and immobile fraction for GFP in WT and 
myoII cells.  Values plotted are mean ± SEM; sample sizes are listed on the bars (See Table 2). p values are 
represented as ns: p >0.05, *: p <0.05, **: p <0.005, ***: p <0.0005 based on ANOVA with Fischer’s LSD 
post-test. 
 
3.4. Alterations to cortical structure and mechanics shift mobility of 
cortexillin I 
To test the effect of cytoskeletal structure on protein dynamics, we perturbed the actin 
cytoskeleton by treating the cells with either latrunculin-A or jasplakinolide.  
Latrunculin-A prevents F-actin assembly by sequestering free G-actin monomers, while 
jasplakinolide enhances actin filament nucleation.  We quantified changes in F-actin 
amount upon treatment with latrunculin-A and jasplakinolide by measuring the relative 
fluorescence intensity of cells stained with phalloidin 15-minutes post-drug treatment [5] 
(Fig. 3.16).  Anti-actin staining was also used to visualize changes in actin level and 
cytoskeletal morphology (Fig. 3.16).  Interestingly, even with 5 μM latrunculin-A, cells 
still had ~50% residual F-actin (~35 μM) (Fig. 3.16B), suggesting sufficient F-actin 
binding sites for the ~1 μM actin crosslinkers [28, 48, 49].  The residual F-actin mostly 
concentrated in puncta illustrating discontinuity of the cytoskeletal network (Fig. 3.16A). 
Latrunculin-A had a drastic effect on cellular mechanics, as 1 μM latrunculin-A-treated 
cells had 12-fold lower cortical tension as measured by micropipette aspiration (Fig. 
3.17), consistent with the 85% reduction in viscoelasticity previously reported for 
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latrunculin-B treatment [26].  5 μM latrunculin-A-treated cells were too soft for 
mechanical measurements.  In contrast, jasplakinolide enhanced the cellular F-actin 
levels ~4-fold inducing the formation of F-actin clusters (Fig. 3.16), and increased 
cortical tension slightly (Fig. 3.17).  Jasplakinolide also increased the recovery time of 
soluble GFP while not affecting its immobile fraction or diffusion (Fig. 3.18).  The 
discontinuity of the cytoskeleton upon latrunculin-A treatment is also reflected by the 
increase in the recovery time and immobile fraction of GFP even though its diffusion is 
unaffected (Fig. 3.18).  Thus, we were able to directly probe the impact of changes in 
cytoskeletal structure and mechanics on protein dynamics by using these two compounds. 
 
Figure 3.16: Perturbation of actin cytoskeleton by latrunculin-A and jasplakinolide. (A) Confocal 
images of TRITC-phalloidin-stained GFP myosin II expressing cells and anti-actin stained cells show 
changes in the cytoskeletal architecture 15 minutes post-treatment with 5 μM latrunculin-A or 2 μM 
jasplakinolide.  (B) Quantification of relative F-actin amount based on the fluorescence intensity of TRITC-
phalloidin and anti-actin staining.  (C) Distribution of normalized fluorescence intensity of TRITC-





Figure 3.17: Effect of latrunculin-A and jasplakinolide on cell mechanics (A) DIC images of 
micropipette aspiration experiments with DMSO, 1 μM latrunculin-A and 2 μM jasplakinolide  (B) Cortical 
tension measurements for DMSO, 1 μM latrunculin-A and 2 μM jasplakinolide-treated cells measured by 
micropipette aspiration (C) Distribution of cortical tension measured by micropipette aspiration on cells 
treated with DMSO, 1 μM latrunculin-A or 2 μM jasplakinolide. 
 
Latrunculin-A or jasplakinolide treatment did not significantly affect cortexillin I 
recovery time, but both compounds appreciably increased its immobile fraction (Fig. 
3.18A, B, Table 3).  Latrunculin-A also increased the recovery time and immobile 
fraction of IQGAP2 (Fig. 3.18A, B, Table 3).  IQGAP2 diffusion was insensitive to both 
drugs (Fig. 3.18C, Table 4).  However, cortexillin I showed two differently diffusing 
populations with latrunculin-A treatment – one with a similar diffusion time as the 
control (~2 ms) and another much slower population (~8 ms) (Fig. 3.18C, Table 4).  This 
slower population likely reflects the diffusion of cortexillin I in actin clusters observed 
upon F-actin staining.  Though jasplakinolide treatment promoted F-actin cluster 
formation, its effect on protein dynamics was not as pronounced (Fig. 3.18, Tables 3-4 ). 
These results demonstrate that the connectivity of the cytoskeleton network is extremely 
important for maintaining normal protein dynamics.  Remarkably, cortexillin I remained 
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localized at the furrow in latrunculin-A-treated cells, though its distribution was non-
uniform (Fig. 3.19A).  Its recovery time and mobility in the furrow were unaffected by 
latrunculin-A (Fig. 3.19B, C).  Thus, the cortexillin I immobile fraction under 
mechanical stress is either saturated or becomes independent of network structure.  In 
contrast, myosin II completely lost its cortical localization upon latrunculin-A treatment 
and formed puncta throughout the cell (Fig. 3.16A) [5].   
 
 
Figure 3.18: Effect of latrunculin-A and jasplakinolide on protein dynamics.  (A) Recovery times and 
immobile fractions of soluble GFP, GFP-actin, GFP-cortexillin I and GFP-IQGAP2 in untreated, 5 μM 
latrunculin A or 2 μM jasplakinolide treated cells as measured by FRAP (see Table 3). (B) Distribution of 
recovery times and immobile fractions for GFP, GFP-actin, GFP-cortexillin I and GFP-IQGAP2 in DMSO, 
5 μM latrunculin-A or 2 μM jasplakinolide-treated cells.  (C) Diffusion times for GFP, GFP-cortexillin I 
and GFP-IQGAP2 in untreated, 5 μM latrunculin-A or 2 μM jasplakinolide treated cells as measured by 
FCS (see Table 4). Cortexillin I shows two differently diffusing populations upon latrunculin-A treatment, 
while the diffusion of GFP and IQGAP2 is unaffected by the pharmacological treatment.  Values plotted 
are mean ± SEM; sample sizes are listed on the bars.  Asterisks represent significance of difference from 
DMSO control, where p values represented as ns: p >0.05, *: p <0.05, **: p <0.005, ***: p <0.0005 based 





Figure 3.19: Effect of latrunculin-A on cortexillin I dynamics in dividing cells.  (A) Confocal images 
showing cleavage furrow recruitment of GFP-cortexillin I in untreated and 5 μM latrunculin-A-treated 
cells. (B) Recovery times and immobile fractions of GFP-cortexillin I in interphase and dividing cells with 
or without 5μM latrunculin-A treatment.  (E) Distribution of recovery times and immobile fractions of 
GFP-cortexillin I in interphase and dividing cells with or without 5 μM latrunculin-A.  Values plotted are 
mean ± SEM; sample sizes are listed on the bars.  Asterisks represent significance of difference from 
DMSO control, where p values represented as ns: p >0.05, *: p <0.05, **: p <0.005, ***: p <0.0005 based 
on ANOVA with Fischer’s LSD post-test. 
 
Latrunculin-A also increased actin mobility and recovery rate, while jasplakinolide had 
no effect (Fig. 3.18A, B).  The increased actin mobility with latrunculin-A is 
quantitatively similar to that at the furrow (Fig. 3.18A, 3.2), further validating the 
importance of cytoskeletal restructuring during cytokinesis (Fig. 3.20).  These dynamic 
features also explain why actin does not show a significant accumulation at the cleavage 
furrow or upon micropipette aspiration [27, 28]. Overall, perturbations to the cytoskeletal 
structure are sufficient to affect changes in the dynamics of cytoskeletal proteins.  
Similarly, protein dynamics are also affected by mechanical stress which leads to 






Figure 3.20: A schematic showing the changes in protein mobility arise from cytoskeletal 
rearrangement under mechanical stress or upon latrunculin-A treatment.  Under high stress, the 
crosslinkers show reduced mobility leading to accumulation, while actin mobility increases even though 
filament amount is relatively unchanged.  Upon latrunculin-A treatment, F-actin amount is reduced and 
actin mobility increases while the crosslinker mobility decreases significantly.   
 
3.5. Proteomic analysis reveals interactions between myosin II, cortexillin I and 
IQGAP2 
The cytokinesis and micropipette aspiration studies have demonstrated how the myosin 
II-cortexillin I mechanosensor and its regulation by IQGAPs is critical for cellular 
contractility and response to mechanical stresses [25].  The protein dynamics experiments 
emphasize the crosstalk between these stress-sensitive elements and their stabilization by 
mechanical stress.  However, the molecular interactions potentiating the mechanosensory 
response remain unknown.  Previous immunoprecipitation studies have shown that 
IQGAP1 and IQGAP2 interact with carboxy- and amino-terminal ends of cortexillin I 
respectively [34, 45, 46] (Figure 3.21).  Since the cortexillin I-binding sites for both 
IQGAPs are distinct, stress-induced changes in IQGAP binding may result in the 
switching between a mechanosensitive and a non-mechanosensitive population of 
cortexillin I.  However, it is likely that other protein-protein interactions might be 
important for regulating myosin II recruitment in the cleavage furrow and other sites of 




The localization of IQGAP2 and cortexillin I at the cleavage furrow is independent of 
many of the proteins known to be involved in mechanosensing.  This hints towards the 
presence of unknown factors that govern protein recruitment.  For example, cortexillin I 
has a PIP2-binding domain [50] and could be directly or indirectly linked to the plasma 
membrane.  IQGAP2 has also been shown to localize at membrane blebs [25], which are 
regions where the plasma membrane becomes detached from the cell cortex.  Thus, the 
possibility of IQGAP2 binding to lipids or membrane proteins needs to be explored.  The 
direct binding between myosin II and IQGAP1 or 2 is also a possible way by which these 
proteins affect mechanosensing. IQGAP has been shown to directly bind myosin tail in 
budding [51] and fission [52] yeast, and is required for myosin recruitment to the actin 
ring during cell division.  In Dictyostelium, IQGAP2 also mediates a 
mechanotransduction pathway that feeds onto the mitotic spindle through the mitotic 
kinesin like protein Kif12.  A previous study using mammalian cells has reported that a 
microtubule end-binding protein interacts with IQGAP1 and small GTPases to regulate 
cell polarity [53].  Similar associations could be important for the mechanosensory 






Figure 3.21: Domain organization of cortexillin I and IQGAP1/2.  Cortexillin I has a calponin 
homology-family actin-binding domain (CH ABD), a coiled coil and a novel ABD and PIP2-binding 
domain at the carboxyl-terminal tail (CT domain; orange).  IQGAP2 is reported as binding to the CH 
domain, and IQGAP1 is reported as binding to the CT domain.  The GAP-related domain (GRD) of the 
IQGAPs is thought to interact with Rac1-family proteins, cortexillin I and filamin. 
 
Thus, we used a proteomic approach for the identification of binding partners for 
cortexillin I and IQGAP2.  We expressed FLAG-tagged constructs of these proteins, and 
used immunoprecipitation to isolate the associated protein complexes.  We used 
cytoskeletal fractionation to distinguish the protein complexes in the cytoskeleton versus 
those in the cytoplasm.  Mass spectrometric analysis identified 12 and 46 cortexillin I-
binding proteins in cytoskeletal and cytoplasmic samples respectively (Table 5).  For 
IQGAP2, 12 and 14 proteins were found in the cytoskeletal and cytoplasmic samples 
respectively (Table 6).  In addition to confirming the binding between cortexillin I and 
IQGAP2, we could also detect cortexillin I binding to Rac1, IQGAP1 and cortexillin II, 
as reported before [34, 45, 46, 54].  We did not detect any interaction between IQGAP2 
and IQGAP1, supporting that these proteins likely bind different populations of 
cortexillin I, and thus have opposite effect on mechanosensing.  Interestingly, both 
cortexillin I and IQGAP2 associate with myosin II, suggesting that these proteins could 
form a macromolecular complex that governs contractility.  The experiments were 
conducted in the presence of Mg
2+
•ATP to prevent myosin II-binding to actin filaments.  
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Further, the myosin II-IQGAP2 interaction is also independent of cortexillin I, based on 
the proteomic analysis for samples from ctxA/ctxB cells expressing FLAG-GFP-IQGAP2 
(Table 7).  Interestingly, mass spectrometry also shows an interaction between RacE and 
myosin II (Table 8), which suggests that the polar cortex proteins could affect myosin II 
function through binding interactions consistent with 14-3-3-regualtion of myosin II 
dynamics [16].  In addition to myosin II, many cytoskeletal and structural proteins having 
known roles in cytokinesis and contractility were also identified as binding partners for 
cortexillin I or IQGAP2 (Fig. 3.22).  For example, mmsdh is found to associate with 
cortexillin I.  Previously, mmsdh overexpression was shown to rescue the cleavage 
furrow localization of the assembly incompetent myosin mutant (3x Asp) [32].  This 
suggests that multiple parallel pathways are involved in cytokinesis regulation.  Further 
characterization of these novel interactions will shed new light on how cells control their 
shape and division.  We will use pair wise coimmunoprecipitation and two-color 
fluorescence cross-correlation spectroscopy to confirm and characterize these 
biochemical associations.  
  
 
Figure 3.22: Selected potential proteins interacting with cortexillin I or IQGAP2, identified by 





Mechanical stresses are important for driving cellular processes like cell division and 
motility, and play a major role in determining cell fate [25, 55, 56].  Understanding the 
effect of mechanical stress on protein dynamics is critical for having predictive power 
over these cellular behaviors.  Here we identified that equatorial protein mobility 
significantly reduces at the cleavage furrow, while that of polar crosslinkers is 
unchanged.  Both biochemical associations and myosin II-mediated remodeling affect 
protein dynamics.  In addition to cleavage furrow contractility, compressive stress 
applied externally also leads to reduced protein mobility.  Even when key contractile 
proteins are eliminated, the cytoskeleton is capable of maintaining fairly normal 
dynamics.  Interestingly, most of the mutant phenotypes in protein dynamics are seen in 
the unstressed, interphase cortex, while the dynamics are unchanged across mutants 
during cytokinesis or upon compression.  Thus, the cell’s contractile system is built as a 
highly adaptive machine, maintaining fairly normal dynamics under mechanical stress 
ensuring fidelity of protein recruitment.  In contrast, in other scenarios mechanical stress 
can exaggerate many mutant phenotypes.  For example, myoII null cells cannot perform 
cytokinesis without substrate adhesion or when challenged by mechanical stress [8, 24].  
Further, changes to cytoskeletal structure are sufficient to drive similar changes in protein 
dynamics, highlighting the importance of network properties in governing protein and 
cellular behaviors.  Myosin II emerges as the major driver of active processes in the 




The mechanical tuning of protein dynamics and recruitment is an important mode of 
regulating cellular responses to physical stimuli, and requires protein-protein interactions 
to be stabilized or disrupted under mechanical load.  Protein-protein stabilization can 
induce protein clustering and provide signal amplification, while disruption can lead to 
signal dissipation.  This is the classical paradigm for any signal transduction system.  
Basic molecular mechanisms for protein clustering in response to mechanical stress 
include catch bond formation and structural cooperativity, while slip bonds allow for 
force-induced disassembly.  These fundamentals are important in directing 
macromolecular assembly of actin crosslinking proteins [5, 28, 57, 58].  Here we have 
demonstrated that these mechanisms are also applicable to scaffolding proteins like 
IQGAP2, emphasizing the importance of network structure and higher order self-
assembly in governing cellular behavior.  Indeed, cellular systems are engineered as 
smart materials where many of the constituents are mechanoresponsive.  
 
Proteomic analysis shows that in addition to binding to each other, both cortexillin I and 
IQGAP2 also associate with myosin II.  Further, the IQGAP2-myosin II interaction is 
independent of cortexillin I.  These findings point towards the existence of 
macromolecular assemblies containing these proteins, which are responsive to 
mechanical stresses in the cortex.  These biochemical interactions could also explain the 
mechanism by which all these proteins are stabilized at the furrow or under stress, as seen 
by the stress-dependent protein mobility shifts.  The exact nature of these interactions is 




5. Future Work 
 
5.1. Biochemical basis of mechanosensing 
Numerous studies have characterized the effect of mechanical stresses on myosin II 
biochemistry.  The myosin II-actin filament binding lifetime is stress-dependent.  Further, 
upon binding to actin filament, myosin II induces conformational changes in the filament 
which promote cooperative binding of additional myosin II heads [5].  Myosin II also 
shows cooperative interactions with cortexillin I, which in turn promote the accumulation 
of these proteins in response to mechanical stress [5].   In vivo studies have shown that 
IQGAP proteins regulate cortexillin I accumulation and dynamics [25].  However, the 
exact nature of these interactions is unknown.  A variety of cellular and biochemical 
assays can be used to study these molecular mechanisms in detail. 
 
5.1.1. In vivo characterization of protein-protein interactions 
The mass spectrometric analysis has identified potential interactions between myosin II-
cortexillin I and IQGAP2. However, the relevance of these interactions in 
mechanosensing is uncharacterized.  For example, certain protein complexes may only 
form when the cytoskeleton is under mechanical stress.  To study in vivo formation of 
these protein complexes, we will use two-color fluorescence cross-correlation 
spectroscopy (FCCS).  This will allow calculation of spatiotemporal changes in apparent 
binding coefficients for protein pairs under physiological conditions.  Also, by studying 
these interactions in different genetic mutant backgrounds, we can analyze the additional 
factors that are important for the formation of these protein complexes.  We will use 
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linked and unlinked GFP-mCherry fusions to calibrate the extent of binding.  Due to 
technical limitations of in vivo FCCS which include low signal-to-noise ratio, poor 
control on protein expression and phototoxicity, we will also extend the analysis to cell 
lysates.   
 
5.1.2. In vitro characterization of the myosin II, cortexillin I and IQGAP 
interactions  
To achieve a molecular understanding of how IQGAPs regulate cortexillin I function, we 
can reduce the system to individual protein interactions.  We have previously purified 
cortexillin I and myosin II [6, 16].  To express and purify the IQGAP proteins, we have 
designed and constructed a highly modular expression vector system based on the pBiEx 
series of vectors (Novagen).  This system can be used for protein expression in either 
bacteria or insect cells, and contains cloning sites compatible with our Dictyostelium 
expression vectors.  The vectors also contain a purification tag, carboxy- or amino- 
terminal fluorophores, and a TEV protease site to allow purification of labeled or 
unlabeled proteins from a single plasmid.  Using this system, we have already expressed 
and partially purified IQGAP2. 
 
We will confirm the in vitro binding of IQGAPs with cortexillin I using an analytical 
Superdex S200 10/30 size exclusion column.  This column offers high resolution 
separation and Stokes radius measurement [59, 60], enabling us to differentiate protein 
complexes from individual proteins and test for competitive binding between the 
IQGAPs.  Size exclusion also allows us to test for oligomerization of IQGAP1 and 
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IQGAP2, and the formation of higher order assemblies.  Since cortexillin I is a known 
actin crosslinking and bundling protein [61-63], we will also determine whether IQGAPs 
affect cortexillin I-actin binding through in vitro co-sedimentation assays and negative 
staining electron microscopy.  Additionally, we can also use quantitative assays such as 
fluorescence polarization anisotropy and isothermal titration calorimetry to measure the 
binding affinities for these proteins.  
 
Myosin assembles into bipolar thick filaments (BTFs) in a salt-dependent manner.  The 
ability to form these filaments is central to myosin II’s force-bearing ability.  One 
possible mode of regulating myosin II contractility could be the modulation of its 
filament forming ability by cortexillin I or IQGAP2.  Thus, we will perform myosin II 
assembly assays with or without purified cortexillin I or IQGAP2.  Collectively, these 
experiments will allow us to answer mechanistic questions about myosin II-cortexillin I-
IQGAP complexes, and how they affect mechanosensing. 
 
5.2. Reconstitution of contractile networks to determine the effect of 
mechanical stress on protein function and dynamics 
After characterizing the myosin II-cortexillin I-IQGAP interactions in vitro, we will then 
test how the IQGAPs impact cortexillin I function using reconstituted actin networks.  
Reconstituted systems are uniquely poised for testing such mechanistic models, as they 
provide the desired level of complexity while eliminating the redundancies commonly 
found in biological systems.  We have developed a custom-built uniaxial stretching 
device to apply force to actin networks (Fig. 5.1), which we can use to characterize the 
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effect of stress on IQGAP and cortexillin I function.  We will measure the dynamics of 
cortexillin I under varying force to determine stress-dependence of actin-cortexillin I 
binding.  By titrating in different amounts IQGAP2 and/or IQGAP1, we can examine 
how IQGAPs affect cortexillin I dynamics and whether they show competitive binding.  
By doing FRAP on the IQGAPs, we can test if there is a change in binding preference of 
cortexillin I for IQGAPs under mechanical stress.  Further, we can test how cortexillin I 
affects the structure of stressed actin networks by imaging fluorescent actin filaments 
under TIRF, and if the IQGAPs regulate the crosslinking properties of cortexillin I.  
Collectively, these experiments will allow us to understand how IQGAPs regulate 
cortexillin I function during mechanosensing. 
 
Figure 5.1: Device for imaging actin networks under stretch. A. Cartoon depicts the stretcher device.  
B. Assembled over a passivated imaging coverslip, the actin network includes biotin-labeled actin, which 
allows adhesion to the avidin-coated, stretching coverslips.  The network can be controllably stretched 





5.3. Mechanosensing regulation in dividing mammalian cells 
We have developed a sophisticated understanding of the mechanosensory system in 
Dictyostelium that tunes contractility during cell division.  The next step is to extend 
these studies to other systems, including mammalian cytokinesis.  We have shown that 
myosin II is recruited to the aspiration site in interphase Drosophila S2 cells and HeLa 
cells (Fig. 5.2).  We are also studying stress-dependent protein accumulation in mitotic 
HeLa cells using micropipette aspiration.  To enhance the fraction of mitotic cells, we 
treated the cells with (+)S-Trityl-L-Cysteine (STLC) which results in metaphase arrest by 
forming a monopolar spindle [64].  Anaphase onset was induced using the Cdk1 
inhibitor, Purvalanol [64].  We have shown that myosin IIA and IIB can accumulate at 
the aspiration site in both metaphase and anaphase cells, though the degree of 
accumulation varies through the cell cycle (Fig. 5.3).   
 
 





Figure 5.3: Myosin IIB is less responsive in anaphase HeLa cells. 
 
We will next determine how other cleavage furrow proteins, such as anillin, MKLP1 and 
RhoA, respond to externally applied stress.  We will also test if the application of 
mechanical stress affects the direction of spindle symmetry breaking during monopolar 
cytokinesis.  Through these studies we will elucidate the pathways regulating 





Table 1: Cell strains used in this study 
Strain Genotype Experimental Applications 
WT Ax3(Rep orf+) 
Phalloidin staining/F-actin 




































































































































































































































Table 2: Mean recovery times () and mean immobile fractions (Fi) for 
proteins in interphase cells, at the cleavage furrow and in compressed 
cells; FRAP Analysis 
 
GFP-cortexillin I 
  Interphase  Furrow  Compression 
WT  2.1 ± 0.2 s, 0.14 ± 0.02 (23)  4.7 ± 0.6 s, 0.36 ± 0.04 (17)  2.9 ± 0.3 s, 0.46 ± 0.06 (14) 
myoII  3.2 ± 0.5 s, 0.26 ± 0.04 (18)  4.1 ± 0.3 s, 0.43 ± 0.04 (23)  2.6 ± 0.5 s, 0.57 ± 0.06 (15) 
iqg2  2.9 ± 0.2 s, 0.29 ± 0.05 (21)  3.6 ± 0.3 s, 0.36 ± 0.05 (23)  2.7 ± 0.3 s, 0.56 ± 0.03 (17) 
iqg1  2.5 ± 0.3 s, 0.20 ± 0.04 (15)  5.8 ± 0.9 s, 0.44 ± 0.05 (15)  2.4 ± 0.3 s, 0.50 ± 0.05 (15) 
iqg1/2  2.4 ± 0.2 s, 0.27 ± 0.04 (23)  2.7 ± 0.4 s, 0.56 ± 0.05 (17)    
racE  1.1 ± 0.2 s, 0.31 ± 0.07 (9)       
S456L  3.4 ± 0.4 s, 0.34 ± 0.03 (23)       
 
GFP-IQGAP2 
  Interphase  Furrow  Compression 
WT  1.6 ± 0.2 s, 0.10 ± 0.02 (14)  2.1 ± 0.2 s, 0.48 ± 0.04 (16)  1.7 ± 0.1 s, 0.27 ± 0.04 (20) 
myoII  1.6 ± 0.2 s, 0.30 ± 0.04 (18)  3.3 ± 0.3 s, 0.48 ± 0.05 (15)  2.7 ± 0.5 s, 0.64 ± 0.04 (15) 
ctxA  1.5 ± 0.2 s, 0.06 ± 0.02 (13)  2.0 ± 0.3 s, 0.36 ± 0.04 (13)  2.1 ± 0.2 s, 0.30 ± 0.02 (14) 
iqg1  1.5 ± 0.3 s, 0.16 ± 0.03 (18)  2.7 ± 0.3 s, 0.43 ± 0.04 (17)  2.3 ± 0.3 s, 0.33 ± 0.04 (16) 
racE  1.4 ± 0.4 s, 0.17 ± 0.04 (16)       
S456L  1.8 ± 0.2 s, 0.22 ± 0.04 (13)       
 
GFP-actin 
  Interphase  Furrow  Compression 
WT  0.75 ± 0.15 s, 0.39 ± 0.05 (17)  1.3 ± 0.2 s, 0.28 ± 0.04 (17)  0.70 ± 0.06 s, 0.29 ± 0.01 (14) 
myoII  0.68 ± 0.12 s, 0.43 ± 0.05 (11)       
ctxA  0.61 ± 0.12 s, 0.35 ± 0.05 (10)       
iqg2  0.46 ± 0.03 s, 0.34 ± 0.05 (15)       
racE  0.61 ± 0.18 s, 0.25 ± 0.07 (10)       
 
GFP 
  Interphase  Furrow  Compression 
WT  0.26 ± 0.03 s, 0.12 ± 0.02 (27)  0.27 ± 0.07 s, 0.12 ± 0.03 (12)  0.66 ± 0.12 s, 0.26 ± 0.04 (14) 
myoII  0.35 ± 0.03 s, 0.14 ± 0.03 (15)     0.50 ± 0.06 s, 0.11 ± 0.02 (15)  
 
The values represent mean ± SEM for recovery times and immobile fractions. The number of 





Table 3: Mean recovery times () and mean immobile fractions (Fi) for proteins latrunculin-A or 
jasplakinolide treated cells; FRAP Analysis 
 
  DMSO  5 μM Latrunculin-A  2 μM Jasplakinolide 
GFP cortI 
(interphase) 
 2.5 ± 0.4 s, 0.25 ± 0.04 (14)  3.5 ± 0.6 s, 0.53 ± 0.05 (13)  2.2 ± 0.4 s, 0.46±0.06 (15) 
GFP cortI 
(furrow) 
 4.6 ± 0.8 s, 0.53 ± 0.10 (9)  6.2 ± 1.1 s, 0.60 ± 0.04 (16)    
GFP IQGAP2  1.5 ± 0.2 s, 0.19 ± 0.03 (14)  2.0 ± 0.2 s, 0.26 ± 0.03 (19)  1.1 ± 0.1 s, 0.14±0.02 (23) 
GFP actin  0.66 ± 0.05 s, 0.36 ± 0.02 (68)  1.1 ± 0.13 s, 0.25 ± 0.03 (41)  0.82 ± 0.08 s, 0.44±0.03 (22) 
GFP  0.26 ± 0.03 s, 0.12 ± 0.02 (27)  0.40 ± 0.03 s, 0.20 ± 0.02 (15)  0.39 ± 0.03 s, 0.10±0.02 (15) 
 





Table 4: Cytosolic diffusion times (  ) and diffusion coefficients (    ) for proteins as measured by FCS 
 
Diffusion in PBS at 22
0
C 
 Molecular weight (kDa) Diffusion time (  ) Diffusion Coefficient (Deff) 
Rhodamine 6G 0.48 kDa 0.033 ± 0.002 ms (34) 426 µm
2
/s* 
His-mCherry 28 kDa 0.15 ± 0.01 ms (11) 94 µm
2
/s 
(Reported value: 95 µm
2
/s*) 




Diffusion in cytoplasm at 22
0
C 
Cell line Cortexillin I IQGAP2 GFP 
WT control 2.4 ± 0.2 ms (20), Deff = 5.8 µm
2
/s 2.9 ± 0.3 ms (18), Deff = 4.8 µm
2
/s 0.78 ± 0.05 ms (20), Deff = 18 µm
2
/s 
WT + compression 4.0 ± 0.3 ms (17), Deff = 3.5 µm
2
/s 3.4 ± 0.4 ms (16), Deff = 4.1 µm
2
/s 1.5 ± 0.1 ms (16), Deff = 9.4 µm
2
/s 
myoII 2.6 ± 0.2 ms (18), Deff = 5.4 µm
2
/s 2.9 ± 0.2 ms (11), Deff = 4.8 µm
2
/s 1.4 ± 0.2 ms (15), Deff = 10 µm
2
/s 
myoII + compression 3.9 ± 0.4 ms (12), Deff = 3.6 µm
2
/s - 0.69 ± 0.06 ms (14), Deff = 20 µm
2
/s 
iqg2 3.1 ± 0.2 ms (16), Deff = 4.5 µm
2
/s - - 
iqg1/2 3.7 ± 0.3 ms (16), Deff = 3.8 µm
2
/s - - 




Treatment Cortexillin I IQGAP2 GFP 
DMSO 2.8 ± 0.4 ms (12), Deff = 5.0 µm
2
/s 2.7 ± 0.4 ms (15), Deff = 5.2 µm
2
/s 0.75 ± 0.10 ms (13), Deff = 19 µm
2
/s 
5 μM latrunculin-A 
P1:2.4 ± 0.1 ms (8), Deff = 5.8 µm
2
/s 
P2:8.1 ± 0.5 ms (7), Deff = 1.7 µm
2
/s 
3.6 ± 0.4 ms (16), Deff = 3.9 µm
2
/s 1.1 ± 0.1 ms (25), Deff = 13 µm
2
/s 
2 μM jasplakinolide 3.2 ± 0.2 ms (20), Deff = 4.4 µm
2
/s 3.2 ± 0.4 ms (18), Deff = 4.4 µm
2




The values represent mean ± SEM for diffusion times. The numbers of measurements is given in parentheses. 




Table 5: List of potential cortexillin I-binding proteins 
Gene Name Protein Name Control Cort I G-value 
Cytoskeletal fraction 
ctxA Cortexillin-1 0.0 16.5 22.8 
rgaA IQGAP1 0.0 16.4 22.7 
ctxB Cortexillin-2 0.0 13.4 18.5 
mhcA Myosin-2 heavy chain 2.3 12.1 7.3 
mfap1 Protein MFAP1 homolog 0.0 4.9 6.8 
gapA IQGAP2 0.0 4.9 6.8 
DDB_ 
0218327 
Putative uncharacterized protein 0.0 3.7 5.1 
DDB_ 
0186471 
RNA-binding region RNP-1 domain-containing 
protein 
0.0 3.4 4.8 
efbA Elongation factor 2 0.0 3.3 4.6 
rac1A Rho-related protein rac1A 0.0 3.3 4.6 
ndufa12 
NADH dehydrogenase[ubiquinone]1 alpha 
subcomplex subunit 12 
0.0 3.0 4.1 
patB Probable plasma membrane ATPase 0.0 2.9 4.1 
mlcE Myosin essential light chain 0.0 2.6 3.6 
  
   
  
Cytoplasmic fraction 
act22 Putative actin-22 0.0 32.2 44.6 
DICPUDRAFT 
_90232 
Putative uncharacterized protein 0.0 29.1 40.3 
rgaA IQGAP1 0.0 25.6 35.5 
mhcA Myosin-2 heavy chain 2.0 31.8 31.5 
ctxA Cortexillin-1 0.0 22.3 30.9 
fkbp5 FK506-binding protein 5 0.0 14.8 20.6 
ctxB Cortexillin-2 0.0 14.6 20.2 
cdcD Cell division cycle protein 48 26.3 65.5 17.3 
gapA IQGAP2 0.0 11.5 16.0 
ctr9 RNA polymerase II complex component 0.0 9.6 13.4 
pyr1-3 Protein PYR1-3 0.0 8.0 11.1 
efbA Elongation factor 2 0.0 6.7 9.3 
DICPUDRAFT 
_93127 
Putative uncharacterized protein 0.0 6.7 9.3 
DDB_ 
0188474 
DUF814 family protein 0.0 6.1 8.4 
eef1a1 Elongation factor 1-alpha 3.9 16.1 7.9 
rps3a 40S ribosomal protein S3 1.4 10.3 7.6 
DDB_ 
G0291301 
Putative bifunctional amineoxidase 0.0 5.5 7.6 
leo1 RNA polymerase-associated protein 0.0 5.4 7.5 
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acpB F-actin-capping protein subunit alpha 0.0 5.3 7.4 
paf1 RNA polymerase II-associated factor 1 0.0 5.0 6.9 
ifdA 
DEAD/DEAH box helicase domain-containing 
protein 
0.0 4.9 6.7 
tufm Elongation factor  Tu, mitochondrial 0.0 4.8 6.6 
DDB_ 
G0282483 
Uncharacterized transmembrane protein 0.0 4.4 6.1 
cdc73 RNA polymerase II complex component 0.0 4.1 5.7 
acly Probable ATP-citrate synthase 0.0 4.0 5.5 
DDB_ 
0169491 
Putative uncharacterized protein 0.0 4.0 5.5 
rpl13 60S ribosomal protein L13 0.0 3.8 5.3 
DD8-14 AAA ATPase domain-containing protein 0.0 3.8 5.2 
metK S-adenosyl methionine synthase 0.0 3.7 5.2 
rps23 40S ribosomal protein S23 0.0 3.5 4.9 
DDB_ 
G0277077 
UvrB/UvrC domain-containing protein 0.0 3.5 4.9 
DDB_ 
0187217 
Putative uncharacterized protein 0.0 3.4 4.7 
mcfQ Mitochondrial substrate carrier family protein Q 0.0 3.3 4.6 
DICPUDRAFT_ 
52099 
40S ribosomal protein S26 0.0 3.2 4.5 
abpC Gelation factor 0.0 3.2 4.4 
tubB Tubulin beta-chain 0.0 3.1 4.3 




0.0 3.1 4.2 
wdr61 WD repeat-containing protein61 0.0 3.1 4.2 
cyc1 Cytochrome c1, heme protein, mitochondrial 0.0 3.1 4.2 
mcfZ Mitochondrial substrate carrier family protein Z 0.0 3.0 4.1 
rpl18 60S ribosomal protein L18 0.0 3.0 4.1 
pdhC 
Dihydrolipoyllysine-residue acetyltransferase 
component of pyruvatede hydrogenase 
complex, mitochondrial 
0.0 2.8 3.9 
DICPUDRAFT_ 
48405 
Putative uncharacterized protein 0.0 2.7 3.7 
rac1A Rho-related protein rac1A 0.0 2.7 3.7 
odhB 
Dihydrolipoyllysine-residue succinyltransferase 
component of 2-oxoglutarate dehydrogenase 
complex, mitochondrial 
0.0 2.7 3.7 





Table 6: List of potential IQGAP2-binding proteins 




act1 Major actin 0.0 27.3 37.91 
hspA 60kDa heat shock protein, mitochondrial 4.7 24.1 14.40 
gapA IQGAP2 0.0 9.8 13.54 
act24 Putative actin-24 0.0 8.8 12.19 
dscA Discoidin-1 subunit A 0.0 6.2 8.60 
ctxB Cortexillin-2 0.0 6.1 8.41 
ctxA Cortexillin-1 0.0 5.1 7.08 
act18 Actin-18 0.0 4.8 6.66 
DDB_ 
0218327 Putative uncharacterized protein 0.0 4.4 6.16 
rpl12 60S ribosomal protein L12 0.0 4.4 6.07 
mlcE Myosin essential light chain 0.0 3.5 4.81 
rplp2 60S acidic ribosomal protein P2 7.9 17.8 3.94 
efbA Elongation factor 2 0.0 2.8 3.91 
  
   
  
Cytoplasmic fraction 
dscA Discoidin-1 subunit A 0.0 17.0 23.60 
mhcA Myosin-2 heavy chain 2.0 19.3 16.14 
gapA IQGAP2 0.0 9.9 13.66 
ctxB Cortexillin-2 0.0 8.0 11.07 
ctxA Cortexillin-1 0.0 7.6 10.49 
dcsC Discoidin-1 subunitB/C 7.2 24.8 10.31 
fkbp5 FK506-binding protein 5 0.0 7.3 10.18 
leo1 RNA polymerase-associated protein 0.0 6.4 8.85 
rplp2 60S acidic ribosomal protein P2 8.3 22.0 6.45 
dscE Discoidin-2 4.6 15.6 6.38 
cadA Calcium-dependent cell adhesion molecule 0.0 4.0 5.55 
rplp1 60S acidic ribosomal protein P1 1.4 8.1 5.27 
cdcD Cell division cycle protein 48 26.3 43.6 4.32 
acpB F-actin-capping protein subunit alpha 0.0 3.0 4.19 
DICPUDRAFT 





Table 7: List of potential IQGAP2-binding proteins in ctxA/B null cells 
Gene Name Protein Name Control IQGAP2 G-value 
Cytoskeletal fraction 
act18 Actin-18 0.0 3.3 4.61 
gapA IQGAP2 0.0 2.6 3.66 
  
   
  
Cytoplasmic fraction 
mhcA Myosin-2 heavy chain 2.0 66.1 76.13 
fkbp5 FK506-binding protein 5 0.0 11.0 15.27 
leo1 RNA polymerase-associated protein 0.0 5.7 7.84 
acpB F-actin-capping protein subunit alpha 0.0 5.4 7.55 
cdcD Cell division cycle protein 48 26.3 49.2 7.07 
ctr9 RNA polymerase II complex component 0.0 4.6 6.40 
mlcE Myosin essential light chain 0.0 4.3 6.00 
gapA IQGAP2 0.0 4.3 5.95 





Table 8: List of potential RacE-binding proteins 
Gene Name Protein Name Control RacE G-value 
Cytoskeletal fraction 
mppA2 
Mitochondrial-processing peptidase subunit 
alpha-2 
2.2 19.4 15.80 
racE Rho-related protein racE 0.0 9.3 12.85 
efbA Elongation factor 2 0.0 8.0 11.08 
atp5b ATP synthase subunit beta, mitochondrial 4.0 18.9 10.64 
mppB 
Mitochondrial-processing peptidase subunit 
beta 
0.0 6.6 9.09 
atp5C1 
ATP synthase subunit gamma, 
mitochondrial 
0.0 6.1 8.41 
DICPUDRAFT 
_52984 
ATP synthase subunit beta 0.0 5.6 7.81 
if1 
F1F0-ATPase putative regulatory protein 
IF1 
0.0 5.1 7.01 
rpl12 60S ribosomal protein L12 0.0 4.8 6.61 
atp5O ATP synthase subunit O, mitochondrial 0.0 4.6 6.39 
acly Probable ATP-citrate synthase 0.0 4.5 6.22 
arcE Actin-related protein2/3 complex subunit 5 0.0 4.4 6.09 
ndufa12 
NADH dehydrogenase[ubiquinone]1 alpha 
subcomplex subunit 12 
0.0 4.4 6.06 




0.0 4.3 5.99 
DDB_0185950 Putative uncharacterized protein 7.3 19.8 5.98 
leo1 RNA polymerase-associated protein 0.0 4.2 5.79 
acpB F-actin-capping protein subunit alpha 0.8 6.3 4.95 
cyc1 Cytochrome c1, hemeprotein, mitochondrial 0.0 3.5 4.89 
DDB_G0283843 Uncharacterized protein 0.8 6.2 4.87 
atp1 ATP synthase subunit alpha, mitochondrial 0.9 6.7 4.86 
sdhA 
Succinate dehydrogenase[ubiquinone] 
flavoprotein subunit, mitochondrial 
0.0 3.2 4.47 
pks16 Probable polyketide synthase 16 0.0 3.2 4.39 
mecr Trans-2-enoyl-CoAreductase, mitochondrial 0.0 3.1 4.36 
DDB_0169073 Putative uncharacterized protein 0.0 3.1 4.29 
DDB_0205386 Putative uncharacterized protein 0.0 3.1 4.29 
sdhB 
Succinate dehydrogenase[ubiquinone] iron-
sulfur subunit, mitochondrial 
0.0 3.0 4.19 
DDB_0186283 Putative uncharacterized protein 0.0 3.0 4.17 
DDB_0191803 Putative uncharacterized protein 0.0 3.0 4.17 




RNA-binding region RNP-1 domain-
containing protein 
0.0 3.0 4.14 
cmfB Conditioned medium factor receptor 1 0.0 2.9 4.07 
act18 Actin-18 0.0 2.8 3.94 
rps23 40S ribosomal protein S23 0.0 2.8 3.84 
rpl13 60S ribosomal protein L13 0.0 2.8 3.84 
ddj1 Heat shock protein 0.0 2.8 3.84 
DDB_G0282483 Uncharacterized transmembrane protein 0.0 2.8 3.84 
cdcD Cell division cycle protein 48 16.3 29.4 3.84 
tubB Tubulin beta chain 0.0 2.3 3.22 
     
Cytoplasmic fraction 
mhcA Myosin-2 heavy chain 2.0 74.9 87.89 
act22 Putative actin-22 0.0 37.9 52.55 
racE Rho-related protein racE 0.0 5.7 7.95 
leo1 RNA polymerase-associated protein 0.0 5.4 7.46 
dscA Discoidin-1 subunit A 0.0 4.7 6.57 
mlcR Myosin regulatory light chain 0.0 4.6 6.44 
fkbp5 FK506-binding protein 5 0.0 4.0 5.50 
cdcD Cell division cycle protein 48 26.3 44.7 4.81 
mlcE Myosin essential light chain 0.0 3.2 4.48 
acpB F-actin-capping protein subunit alpha 0.0 2.8 3.84 
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